Literature DB >> 25645703

Bone. Osteocyte-specific activation of the canonical Wnt-β catenin pathway stimulates bone formation.

Joana Osório.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25645703     DOI： 10.1038/nrendo.2015.11

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone.

Authors:  Xiaolin Tu; Jesus Delgado-Calle; Keith W Condon; Marta Maycas; Huajia Zhang; Nadia Carlesso; Makoto M Taketo; David B Burr; Lilian I Plotkin; Teresita Bellido
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205
  1 in total
  4 in total

1.  Small molecule T63 suppresses osteoporosis by modulating osteoblast differentiation via BMP and WNT signaling pathways.

Authors:  Xiao-Li Zhao; Jin-Jing Chen; Guo-Ning Zhang; Yu-Cheng Wang; Shu-Yi Si; Lin-Feng Chen; Zhen Wang
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

2.  The Osteocyte Stimulated by Wnt Agonist SKL2001 Is a Safe Osteogenic Niche Improving Bioactivities in a Polycaprolactone and Cell Integrated 3D Module.

Authors:  Yangxi Liu; Xiaojie Ruan; Jun Li; Bo Wang; Jie Chen; Xiaofang Wang; Pengtao Wang; Xiaolin Tu
Journal:  Cells       Date:  2022-02-28       Impact factor: 6.600

3.  A novel decellularized matrix of Wnt signaling-activated osteocytes accelerates the repair of critical-sized parietal bone defects with osteoclastogenesis, angiogenesis, and neurogenesis.

Authors:  Xiaofang Wang; Yufei Ma; Jie Chen; Yujiao Liu; Guangliang Liu; Pengtao Wang; Bo Wang; Makoto M Taketo; Teresita Bellido; Xiaolin Tu
Journal:  Bioact Mater       Date:  2022-08-16

4.  Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity.

Authors:  Binghan Li; Dan Lu; Yuqing Chen; Minghui Zhao; Li Zuo
Journal:  Int J Mol Sci       Date:  2016-04-22       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.